Protalix Biotherapeutics (NY: PLX )
1.125
+0.015
(+1.35%)
Streaming Delayed Price
Updated: 12:06 PM EDT, Jun 18, 2024
Add to My Watchlist
All News about Protalix Biotherapeutics
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.pixabay.com/photo/2021/05/27/02/07/gamestop-6286876_1280.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/10/23/image16.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Preview: Protalix BioTherapeutics's Earnings
August 04, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/05/04/plx.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/ep_us_feature_image_1642.jpeg?width=1200&height=800&fit=crop)
Earnings Preview For Protalix BioTherapeutics
February 24, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Earnings Preview: Protalix BioTherapeutics
March 13, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Earnings Preview For Protalix BioTherapeutics
November 03, 2023
Via Benzinga
Looking Into Protalix BioTherapeutics's Return On Capital Employed
December 23, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 07, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/05/10/aapharma_7.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-stock-market.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/02/27/image_7.jpg?width=1200&height=800&fit=crop)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_6576.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_130.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/06/image15.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://public.newsdirect.com/213820402/MGRd4NQF.png)
Protalix and Chiesi Resubmit FDA Application For Rare Disease Treatment
November 30, 2022
Via News Direct
Exposures
Product Safety
Protalix and Chiesi Resubmit FDA Application For Rare Disease Treatment
November 30, 2022
Via TheNewswire.com
Exposures
Product Safety
![](https://cdn.benzinga.com/files/images/story/2022/11/29/screenshot_2022-11-29_at_7.21.53_pm.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_9842.jpeg?width=1200&height=800&fit=crop)
![](https://public.newsdirect.com/376851953/MvxqxpKe.png)
![](https://cdn.benzinga.com/files/images/story/2022/09/20/screenshot_2022-09-20_at_5.44.02_pm.png?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.